4//SEC Filing
Nolan Mangini Siobhan 4
Accession 0001209191-20-010858
CIK 0001433714other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 9:09 PM ET
Size
29.5 KB
Accession
0001209191-20-010858
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
CFO & Treasurer
Transactions
- Exercise/Conversion
Class B Common Stock
2020-02-16+23,063→ 447,953 total - Exercise/Conversion
Class B Common Stock
2020-02-16+25,862→ 473,815 total - Exercise/Conversion
Restricted Stock Units (RSU)
2020-02-16−1,875→ 0 total→ Class B Common Stock (1,875 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2020-02-16−6,250→ 25,000 total→ Class B Common Stock (6,250 underlying) - Exercise/Conversion
Class B Common Stock
2020-02-16+15,625→ 407,390 total - Sale
Class B Common Stock
2020-02-18$1.23/sh−34,817$42,724→ 438,998 total - Exercise/Conversion
Class B Common Stock
2020-02-16+1,875→ 391,765 total - Exercise/Conversion
Class B Common Stock
2020-02-16+6,250→ 413,640 total - Exercise/Conversion
Restricted Stock Units (RSU)
2020-02-16−25,862→ 362,069 total→ Class B Common Stock (25,862 underlying) - Exercise/Conversion
Class B Common Stock
2020-02-16+11,250→ 424,890 total - Exercise/Conversion
Restricted Stock Units (RSU)
2020-02-16−15,625→ 31,250 total→ Class B Common Stock (15,625 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2020-02-16−11,250→ 90,010 total→ Class B Common Stock (11,250 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2020-02-16−23,063→ 276,750 total→ Class B Common Stock (23,063 underlying)
Footnotes (9)
- [F1]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
- [F4]1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F5]1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F6]1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F7]1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F8]1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F9]1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
CASTLIGHT HEALTH, INC.
CIK 0001433714
Entity typeother
Related Parties
1- filerCIK 0001679464
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 9:09 PM ET
- Size
- 29.5 KB